|
Age (years)
|
59 ± 13
|
62 ± 12
|
0.012
|
|
Men (%)
|
73.8
|
76.5
|
0.562
|
|
Type 2 diabetes (%)
|
91.1
|
96.1
|
0.061
|
|
Duration of diabetes (years)
|
18 ± 9
|
19 ± 10
|
0.617
|
|
Diabetic retinopathy (%)
|
92.7
|
77.5
|
<0.001
|
|
Medication for diabetes (none/oral/insulin)
|
25.1/6.3/68.6
|
25.5/17.2/57.3
|
0.002
|
|
BMI (kg/m2)
|
24.7 ± 4.2
|
24.9 ± 4.8
|
0.648
|
|
Systolic blood pressure (mmHg)
|
157 ± 24
|
151 ± 19
|
0.007
|
|
Diastolic blood pressure (mmHg)
|
78 ± 13
|
77 ± 13
|
0.764
|
|
Smoking (current or ever, %)
|
62.3
|
58.8
|
0.537
|
|
ASCVD (%)
|
57.1
|
44.1
|
0.012
|
|
Date of hemodialysis initiation
| | | |
|
January 2003–December 2008
|
77.5
|
33.3
|
<0.001
|
|
January 2009–March 2013
|
22.5
|
66.7
| |
|
Laboratory data
|
|
Hemoglobin (g/dL)
|
8.8 ± 1.2
|
9.3 ± 1.2
|
<0.001
|
|
HbA1c (NGSP) (%)
|
6.2 ± 1.1
|
6.3 ± 1.0
|
0.522
|
|
Triglycerides (mg/dL)
|
125 (38–1358)
|
114 (29–887)
|
0.163
|
|
HDL cholesterol (mg/dL)
|
42 ± 15
|
44 ± 14
|
0.202
|
|
LDL cholesterol (mg/dL)
|
106 ± 39
|
96 ± 36
|
0.009
|
|
Albumin (g/dL)
|
3.0 ± 0.5
|
3.2 ± 0.4
|
<0.001
|
|
Creatinine (mg/dL)
|
8.58 ± 2.25
|
8.26 ± 1.89
|
0.123
|
|
eGFR (mL/min/1.73 m2)
|
5.7 ± 1.5
|
6.0 ± 2.5
|
0.130
|
|
Total bilirubin (mg/dL)
|
0.2 (0.1–0.2)
|
0.4 (0.3–0.8)
|
<0.001
|
|
AST (U/L)
|
17 ± 10
|
17 ± 8
|
0.977
|
|
ALT (U/L)
|
13 ± 12
|
12 ± 9
|
0.593
|
|
γ-GT (U/L)
|
18 (5–235)
|
17 (7–416)
|
0.828
|
